Sponsor or institution
Clinical trials and research at Luminary Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 5 NIH-funded research projects at this institution, with $3.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5NIH research projects
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Allogeneic BAFF-based CAR T Cells for B Cell Cancers
A new donor-derived CAR T cell therapy using BAFF ligands is being explored to treat B cell malignancies like mantle cell lymphoma, aiming for better persistence and easier access than current autologous treatments.
-
Off-the-shelf BAFF-targeting CAR T for B‑cell cancers
An off-the-shelf CAR T-cell therapy that uses the BAFF ligand to target B‑cell cancers like mantle cell lymphoma.
-
A new CAR T cell therapy targeting ovarian cancer
This study is testing a new type of CAR T cell therapy for women with ovarian cancer that uses special immune cells to better target the cancer and includes a safety feature to help protect patients from side effects.
-
New CAR T-cell therapy targeting B cells for lupus treatment
This study is testing a new type of CAR T-cell therapy designed to help people with systemic lupus erythematosus (SLE) by targeting and removing the harmful B cells that contribute to the disease, with the hope of improving treatment outcomes and safety.
-
New CAR T cell therapy for B cell cancers
This study is testing a new treatment using special immune cells to help people with mantle cell lymphoma, aiming to make the therapy work better and last longer by using a unique approach to boost the immune response against the cancer.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.